Budesonide provides lasting relief for Crohn's disease patients

September 12, 2005

In a study published in The American Journal of Gastroenterology, researchers found that budesonide capsules are an effective treatment to prolong and maintain the period of remission of Crohn's Disease. Previous studies have demonstrated that budesonide is effective for inducing remission of Crohn's disease.

Four double-blind, placebo-controlled trials were conducted with identical protocols in which patients with Crohn's Disease, and medically induced remission, received a treatment of oral budesonide for 12 months. Results showed that budesonide taken at 6 mg/day is effective for prolonging time to relapse and for significantly reducing rates of relapse.

"Long-term treatment with budesonide is well-tolerated and the frequency and types of adverse events are similar to placebo," states lead researcher,William J. Sandborn, MD. "Safety of a long-term medication is obviously important, but how well a patient tolerates their medication is also important and can affect patient adherence to therapy."

Crohn's disease is a long-term disease that results from inflammation of the digestive tract. It is a debilitating sickness, even for patients who are classified as having mild to moderate disease. Currently, there are no treatment options available that prevents recurrence of symptoms.

"As stated, this disease is recurring in nature, so extending the time a patient can be symptom-free or with diminished symptoms is an important feature of treatment. Budesonide capsules are a treatment option for Crohn's disease that has been shown in studies not only to be very effective in relieving symptoms, but also in extending the time before patients experience a recurrence."
-end-
This study is published in The American Journal of Gastroenterology. Media wishing to receive a PDF of the article contact medicalnews@bos.blackwellpublishing.net.

Dr. William J. Sandborn is a board certified gastroenterologist with specific expertise in inflammatory bowel disease. He has published extensively in this field, both nationally and internationally. Dr. Sandborn can be reached for questions and interviews at sandborn.william@mayo.edu.

About The American Journal of Gastroenterology
The American Journal of Gastroenterology, the official publication of the American College of Gastroenterology, is THE clinical journal for all practicing gastroenterologists, hepatologists and GI endoscopists. With an impact factor of 4.716, it is the authoritative clinical source in the field of gastroenterology. With a broad-based, rigorous, interdisciplinary approach, the journal presents the latest important information in the field of gastroenterology including original manuscripts, meta-analyses and reviews, health economic papers, debates and consensus statements of clinical relevance in gastroenterology. The reports will highlight new observations and original research, results with innovative treatments and all other topics relevant to clinical gastroenterology. Case reports highlighting disease mechanisms or particularly important clinical observations and letters on articles published in the Journal are included.

About Blackwell Publishing
Blackwell Publishing is the world's leading society publisher, partnering with more than 600 academic and professional societies. Blackwell publishes over 750 journals annually and, to date has published close to 6,000 text and reference books, across a wide range of academic, medical, and professional subjects.

Blackwell Publishing Ltd.

Related Gastroenterology Articles from Brightsurf:

Digestive symptoms are prominent among COVID-19 patients reveals study in The American Journal of Gastroenterology
The American Journal of Gastroenterology published today a new study that reveals digestive symptoms, including diarrhea, are common in COVID-19 patients.

Baylor Scott & White gastroenterology researchers share key takeaways from DDW 2019
Dr. Stuart J. Spechler among researchers from Baylor Scott & White Research Institute available to provide key takeaways from Digestive Disease Week 2019.

The Lancet Gastroenterology & Hepatology: Colorectal cancer incidence on the rise among young adults in several high-income countries
The incidence of colon and rectal cancer in adults younger than 50 years has increased substantially over the latest available 10-year period in several high-income countries, going against a decline or stabilisation trend in the incidence of colorectal cancers within the overall populations of high-income countries.

The Lancet Gastroenterology & Hepatology and The Lancet Respiratory Medicine: Whole body MRI may help to detect spread of cancers more quickly
Trials with people with newly-diagnosed colorectal and non-small cell lung cancer suggest that whole body MRI could reduce the time it takes to diagnose the stage of cancers.

The Lancet Gastroenterology & Hepatology: Hypnotherapy could help relieve irritable bowel syndrome symptoms
Peer-reviewed / Randomised Controlled Trial / People Gut-directed hypnotherapy delivered by psychologists appears as effective in group or individual sessions, potentially offering a new treatment option for irritable bowel syndrome in primary and secondary care

Low FODMAP diet and IBS recently published by Dove Medical Press
The evidence to date indicates that restriction of FODMAPs is an effective dietary intervention for reducing IBS symptoms.

Gastroenterology Special Issue confirms: You are what you eat
The editors of Gastroenterology, the official journal of the American Gastroenterological Association, are pleased to announce the publication of this year's highly anticipated special 13th issue on food, the immune system and the gastrointestinal tract.

Bariatric surgery can benefit some obese children and teens, reports Journal of Pediatric Gastroenterology and Nutrition
Bariatric surgery -- as a last resort when conservative interventions have failed -- can improve liver disease and other obesity-related health problems in severely obese children and adolescents, according to a position paper in the Journal of Pediatric Gastroenterology and Nutrition, official journal of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.

What's the current role of liver biopsy in children? Position paper in Journal of Pediatric Gastroenterology and Nutrition
While noninvasive alternatives are increasingly available, liver biopsy still provides essential information in some children with liver disease, according to a new position paper in the Journal of Pediatric Gastroenterology and Nutrition, official journal of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.

AGA introduces new journal: Cellular and Molecular Gastroenterology and Hepatology
The American Gastroenterological Association is pleased to welcome a new member to its family of journals: Cellular and Molecular Gastroenterology and Hepatology.

Read More: Gastroenterology News and Gastroenterology Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.